An expert at ESMO 2026 explains how liquid biopsy and ESR1 testing can help guide treatment for people with HR-positive metastatic breast cancer.
|Videos|March 15, 2017
Jubilee Brown on Genetic Counseling for Patients With Breast and Ovarian Cancer
Author(s)Jubilee Brown, M.D.
Jubilee Brown, M.D., obstetrician-gynecologist, Levine Cancer Institute, Carolinas HealthCare System, discusses genetic counseling for patients with breast and ovarian cancer.
Advertisement
Jubilee Brown, M.D., obstetrician-gynecologist, Levine Cancer Institute, Carolinas HealthCare System, discusses genetic counseling for patients with breast and ovarian cancer.
Genetic counseling can work as a way of prevention for patients who may be at risk for certain cancers, Brown says.
Advertisement
Related to this article
Libtayo survival data, a rare positive osteosarcoma trial and new ADCs for breast, lung and stomach cancers are among ESMO 2026 abstracts to watch.
Martha Carlson reflects on her 11 years with metastatic breast cancer and explores how resilience, purpose and the stories we tell ourselves shape the cancer experience.
A study found that 1 in 9 older cancer survivors developed a second cancer, highlighting why routine screening remains important beyond five years.
After breast cancer at 30, Aisha shares her journey through motherhood, a double mastectomy, body image struggles and the challenges of survivorship.
A study found that sentinel lymph node biopsy rarely missed remaining cancer in patients with locally advanced breast cancer whose lymph nodes responded to chemotherapy before surgery.
Lower income, later diagnosis and gaps in treatment drove most of the excess deaths among rural patients, according to new research.
The FDA has cleared TumorSight Risk, software that uses a patient's existing breast MRI, pathology and clinical information to estimate the chance that early HR-positive, HER2-negative breast cancer will come back within five and 10 years.
Advertisement
Advertisement
Trending on CURE
1
FDA Grants Traditional Approval to Keytruda for TMB-H Solid Tumors
2
Psychiatrist Answers Questions About Family and Relationships During Cancer
3
FDA Clears AI Tool Using MRI to Gauge Breast Cancer Recurrence
4
What Liquid Biopsy and ESR1 Mutations Mean in Breast Cancer
5